Angaran D M, Dias V C, Arom K V, Northrup W F, Kersten T E, Lindsay W G, Nicoloff D M
Ann Surg. 1984 Jan;199(1):107-11. doi: 10.1097/00000658-198401000-00019.
The influence of cefamandole and vancomycin used for prophylaxis on the warfarin anticoagulation response in 60 cardiac valve replacement patients during the postoperative period is presented. Patients were divided into two groups, hyper-responders prothrombin time (PT) greater than or equal to 32 sec, 48 hr after the initial warfarin dose (GrIHR), or normal responders PT less than 32 sec (GrIINR). Fifteen patients (25%) were in GrIHR (PT 44.3 +/- 10.5) and 45 in GrIINR (21 +/- 5). Fourteen of the 15 GrIHR patients received cefamandole and 1 of the 15 GrIHR patients received vancomycin p less than 0.05, as prophylaxis. Warfarin sensitivity was assessed using a warfarin dose index (WDI) calculated in the initial postoperative period (WDIINT) and at discharge (WDIDIS). GrIHR patients had greater WDIINT and WDIDIS compared to GrIINR p less than 0.001. Baseline prothrombin time measured 8 hours prior to start of warfarin therapy (PTBL), was linearly correlated to the WDIINT with r = 0.8, p less than 0.001 in cefamandole patients only. The data suggests that cefamandole increases warfarin sensitivity early in the postoperative course of oral anticoagulation therapy, which may lead to excessively high prothrombin times with the possibility for serious bleeding.
本文介绍了头孢孟多和万古霉素用于预防对60例心脏瓣膜置换术后患者华法林抗凝反应的影响。患者分为两组,初始华法林剂量后48小时凝血酶原时间(PT)大于或等于32秒的高反应者(GrIHR),或PT小于32秒的正常反应者(GrIINR)。15例患者(25%)属于GrIHR(PT 44.3±10.5),45例属于GrIINR(21±5)。15例GrIHR患者中有14例接受头孢孟多预防,15例GrIHR患者中有1例接受万古霉素预防(p<0.05)。使用术后初期(WDIINT)和出院时(WDIDIS)计算的华法林剂量指数(WDI)评估华法林敏感性。与GrIINR相比,GrIHR患者的WDIINT和WDIDIS更高(p<0.001)。仅在头孢孟多治疗的患者中,华法林治疗开始前8小时测量的基线凝血酶原时间(PTBL)与WDIINT呈线性相关,r = 0.8,p<0.001。数据表明,头孢孟多在口服抗凝治疗术后早期增加华法林敏感性,这可能导致凝血酶原时间过高,有严重出血的可能性。